Health Care Professionals Partnering Careers Contact Us

Pharmaceuticals in the Environment

Pharmaceuticals and their byproducts have found their way into the environment through patient use for as long as medicines have been around. Awareness of this issue has increased with the development of analytical technologies that detect trace amounts of pharmaceuticals and other organic chemicals in the aquatic environment. There is concern that trace amounts of medicines, known as Pharmaceuticals in the Environment (PIE), could affect aquatic life and human health.

Because Pfizer is committed to responsible environmental and product stewardship, we work closely with the scientific community, regulatory agencies, patient groups and non-governmental organizations to learn more about pharmaceuticals in the environment and their potential impacts. We're also taking direct action by initiating industry-leading strategies to understand and minimize potential impacts from PIE.

Dig Deeper

 
PIE Overview

Pfizer was an active participant in the pharmaceutical industry's development of the PhATE model — a scientific tool that can be used to more realistically estimate the concentration and distribution of active pharmaceutical ingredients discharged into U.S. surface waters.
pdf

If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page.



Top

Text Size A A A
Goals and Commitments

Pfizer recognizes the public's concerns and has taken action.

SMARxT Disposal

Pfizer is partnering with other pharmaceutical companies and government agencies to further explore unused medicine disposal options.

Explore additional resources: